英文名稱 | Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1) |
---|---|
中文名稱 | 格菲妥單抗 |
CAS號 | 2229047-91-8 |
外觀 | Colorless to light yellow liquid |
儲存條件 | store at -20°C |
英文名稱 | Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1) |
---|---|
中文名稱 | 格菲妥單抗 |
CAS號 | 2229047-91-8 |
外觀 | Colorless to light yellow liquid |
儲存條件 | store at -20°C |
Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab is used as an effective therapy for relapsed or refractory diffuse large B-cell lymphoma.
PMID: 34941996 PMCID: PMC8945294 DOI: 10.1182/bloodadvances.2021005954
PMID: 33739857 PMCID: PMC8210975 DOI: 10.1200/JCO.20.03175
PMID: 34953862 DOI: 10.1016/j.xphs.2021.12.019
PMID: 33406104 PMCID: PMC7787458 DOI: 10.1371/journal.pone.0241091